Koyfin Home > Directory > Health Care > Aratana Theraptcs > Capital Expenditures

Aratana Theraptcs Capital Expenditures Chart (PETX)

Aratana Theraptcs annual/quarterly Capital Expenditures from 2013 to 2017.
  • Aratana Theraptcs Capital Expenditures for the quarter ending December 12, 2017 was $0m a 413.33% increase of 0m year over year
  • Aratana Theraptcs Capital Expenditures for the last 12 months ending September 09, 2018 was $0m a 106.67% increase of 0m year over year
  • Aratana Theraptcs Annual Capital Expenditures for 2017 was $0m a -7,100.00% increase of 0m from 2016
  • Aratana Theraptcs Annual Capital Expenditures for 2016 was $0m a -3,018.06% increase of 2m from 2015
  • Aratana Theraptcs Annual Capital Expenditures for 2015 was $-2m a 79.02% decrease of -2m from 2014
Other Cash Flow Metrics:
  • Aratana Theraptcs Cash Flow from Operations for the quarter ending September 09, 2018 was $-4m a 107.86% decrease of -5m year over year
  • Aratana Theraptcs Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-8m a 102.92% decrease of -8m year over year
  • Aratana Theraptcs Total Revenue for the quarter ending September 09, 2018 was $22m a 51.49% increase of 11m year over year
View Chart On Koyfin

Quarterly PETX Capital Expenditures Data

12/2017$0m
09/2017$0m
06/2017$0m
12/2016$0m
09/2016$0m
06/2016$0m
03/2016$0m
12/2015$0m
09/2015$-1m
06/2015$-1m

Annual PETX Capital Expenditures Data

2017$0m
2016$0m
2015$-2m
2014$0m
2013$0m
2012$0m